These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15718328)

  • 1. Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions.
    Gasparini G; Longo R; Fanelli M; Teicher BA
    J Clin Oncol; 2005 Feb; 23(6):1295-311. PubMed ID: 15718328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic inhibitors: a new therapeutic strategy in oncology.
    Gasparini G; Longo R; Toi M; Ferrara N
    Nat Clin Pract Oncol; 2005 Nov; 2(11):562-77. PubMed ID: 16270097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of antiangiogenic therapy with other modalities.
    O'Reilly MS
    Cancer J; 2002; 8 Suppl 1():S89-99. PubMed ID: 12075706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of antiangiogenic agents.
    Rehman S; Jayson GC
    Oncologist; 2005 Feb; 10(2):92-103. PubMed ID: 15709211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation combined with antiangiogenic and antivascular agents.
    O'Reilly MS
    Semin Radiat Oncol; 2006 Jan; 16(1):45-50. PubMed ID: 16378906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
    Kerbel RS
    Science; 2006 May; 312(5777):1171-5. PubMed ID: 16728631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitors in the management of breast cancer.
    Bossung V; Harbeck N
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):79-86. PubMed ID: 19952746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined antiangiogenic and immune therapy of prostate cancer.
    Huang X; Raskovalova T; Lokshin A; Krasinskas A; Devlin J; Watkins S; Wolf SF; Gorelik E
    Angiogenesis; 2005; 8(1):13-23. PubMed ID: 16132614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategies and future directions of antiangiogenic tumor therapy.
    Zhang ZL; Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of radiation therapy and antiangiogenic therapy.
    O'Reilly MS
    Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The present and future of angiogenesis-directed treatments of colorectal cancer.
    O'Dwyer PJ
    Oncologist; 2006 Oct; 11(9):992-8. PubMed ID: 17030640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiogenesis in cancer patients.
    Verheul HM; Pinedo HM
    Expert Opin Emerg Drugs; 2005 May; 10(2):403-12. PubMed ID: 15934875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative therapies for advanced ovarian cancer.
    Trimble EL
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):24-30. PubMed ID: 10952123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy.
    Ansiaux R; Baudelet C; Jordan BF; Crokart N; Martinive P; DeWever J; Grégoire V; Feron O; Gallez B
    Cancer Res; 2006 Oct; 66(19):9698-704. PubMed ID: 17018628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy.
    Tonra JR; Hicklin DJ
    Immunol Invest; 2007; 36(1):3-23. PubMed ID: 17190647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of the tumor vascular-disrupting agent ASA404 (vadimezan, DMXAA): current status and future opportunities.
    Head M; Jameson MB
    Expert Opin Investig Drugs; 2010 Feb; 19(2):295-304. PubMed ID: 20050824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapy in nonsmall cell lung cancer.
    Gutierrez M; Giaccone G
    Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic scheduling of lower dose cancer chemotherapy.
    Gately S; Kerbel R
    Cancer J; 2001; 7(5):427-36. PubMed ID: 11693902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.